MATEON ANNOUNCES COMPLETION OF ARTI-19 AND PUBLICATION OF POSITIVE INTERIM DATA
02 févr. 2021 07h00 HE
|
Mateon Therapeutics, Inc.
AGOURA HILLS, California, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious diseases,...
Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19
11 déc. 2020 23h15 HE
|
BioNTech SE
U.S. FDA authorizes COVID-19 mRNA vaccine for emergency use; companies are prepared to deliver first doses in the U.S. immediatelyPfizer and BioNTech previously announced an agreement with the U.S....
FDA-Beratungsausschuss unterstützt die erste U.S.-Notfallzulassung für Pfizers und BioNTechs COVID-19-Impfstoff
10 déc. 2020 18h51 HE
|
BioNTech SE
FDA wird voraussichtlich innerhalb der nächsten Tage eine Entscheidung bezüglich einer Notfallzulassung treffenDas positive Abstimmungsergebnis basiert auf der Gesamtheit der eingereichten...
Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.
10 déc. 2020 18h51 HE
|
BioNTech SE
FDA expected to make a decision on Emergency Use Authorization in the coming daysPositive vote based on totality of scientific evidence presented by the companies, including Phase 3 efficacy and...
Pfizer und BioNTech erhalten weltweit erste Zulassung für COVID-19-Impfstoff
02 déc. 2020 02h05 HE
|
BioNTech SE
Die britische Regulierungsbehörde MHRA genehmigt die Lieferung von COVID-19-Impfstoff zur Notfallversorgung (gemäß Verordnung 174); erste Lieferungen werden innerhalb weniger Tage im Vereinigten...
Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19
02 déc. 2020 02h05 HE
|
BioNTech SE
U.K. regulator, MHRA, authorizes supply of COVID-19 mRNA vaccine for emergency supply under Regulation 174; Companies are ready to deliver the first doses to the U.K. immediatelyFirst authorization...
Pfizer und BioNTech reichen Antrag auf Notfallzulassung für COVID-19-Impfstoff bei der U.S. FDA ein
20 nov. 2020 06h45 HE
|
BioNTech SE
Neben der heutigen Einreichung bei der FDA haben die Unternehmen bereits eine rollierende Einreichung für den Review-Prozess bei Behörden weltweit gestartet, einschließlich Australien, Kanada, Europa,...
Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine
20 nov. 2020 06h45 HE
|
BioNTech SE
In addition to today’s submission to the FDA, the companies have already initiated rolling submissions across the globe including in Australia, Canada, Europe, Japan and the U.K., and plan to submit...
Precipio Announces Commercial Launch of COVID-19 Antibody Test
30 juil. 2020 10h15 HE
|
Precipio, Inc.
NEW HAVEN, Conn., July 30, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), is announcing its COVID-19 strategy, and its intent to contribute to the battle...
Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test
12 juin 2020 08h00 HE
|
Cue Health Inc.
SAN DIEGO, June 12, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (“Cue”), a healthcare technology company, announced today that it has received Emergency Use Authorization (“EUA”) from the U.S. Food and...